Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acral Lentiginous Malignant Melanoma”

46 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 46 results

Early research (Phase 1)Active Not RecruitingNCT03025256
What this trial is testing

Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease

Who this might be right for
Acral Lentiginous MelanomaCentral Nervous System MelanomaClinical Stage IV Cutaneous Melanoma AJCC v8+7 more
M.D. Anderson Cancer Center 75
Not applicableLooking for participantsNCT06952400
What this trial is testing

The Registry Study of Genetic Alterations of Melanoma in Taiwan

Who this might be right for
Primary Melanoma of the Extremity
National Health Research Institutes, Taiwan 250
Testing effectiveness (Phase 2)Study completedNCT00788775
What this trial is testing

Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma

Who this might be right for
Mucosal Lentiginous MelanomaAcral MelanomaMelanoma
Dana-Farber Cancer Institute 20
Testing effectiveness (Phase 2)Looking for participantsNCT06965231
What this trial is testing

Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial

Who this might be right for
Melanoma of SkinAcral MelanomaStage II Melanoma
Fudan University 58
Testing effectiveness (Phase 2)Ended earlyNCT02978443
What this trial is testing

A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab

Who this might be right for
Acral Lentiginous MelanomaMucosal Melanoma
Georgetown University 14
Testing effectiveness (Phase 2)Study completedNCT01395121
What this trial is testing

A Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has Spread

Who this might be right for
Mucosal Lentiginous MelanomaAcral Lentiginous Malignant Melanoma
Institute of Cancer Research, United Kingdom 29
Testing effectiveness (Phase 2)UnknownNCT03955354
What this trial is testing

PD-1 Antibody SHR-1210 Combined With Apatinib of First-line Treatment of Advanced Acral Melanoma

Who this might be right for
Melanoma
Peking University Cancer Hospital & Institute 30
Early research (Phase 1)Ended earlyNCT04653038
What this trial is testing

Evaluate the Safety and Efficacy of MGD013 in Patients With Melanoma

Who this might be right for
Unresectable, Recurrent or Metastatic MelanomaUntreated Mucosal or Acral Lentiginous Melanoma
Zai Lab (Shanghai) Co., Ltd. 92
Testing effectiveness (Phase 2)Looking for participantsNCT04331093
What this trial is testing

Neoadjuvant SHR-1210 Plus Apatinib for Resectable Stage III-IV Acral Melanoma

Who this might be right for
Acral Melanoma
Di Wu 40
Early research (Phase 1)Study completedNCT05628883
What this trial is testing

Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma

Who this might be right for
Metastatic MelanomaUnresectable MelanomaAcral Melanoma+7 more
H. Lee Moffitt Cancer Center and Research Institute 17
Testing effectiveness (Phase 2)Study completedNCT02875132
What this trial is testing

Pembrolizumab in Advanced/Metastatic Acral Lentiginous Melanoma

Who this might be right for
Acral Lentiginous Melanoma
Chinese University of Hong Kong 9
Large-scale testing (Phase 3)Looking for participantsNCT05549297
What this trial is testing

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

Who this might be right for
Advanced Melanoma
Immunocore Ltd 540
Large-scale testing (Phase 3)Ended earlyNCT04277663
What this trial is testing

The Study of IBI310 in Combination With IBI308 Compared to High-Dose Interferon In Patients With Acral Melanoma That Has Been Removed by Surgery

Who this might be right for
Acral Melanoma That Has Been Removed by Surgery
Innovent Biologics (Suzhou) Co. Ltd. 136
Testing effectiveness (Phase 2)Ended earlyNCT01092728
What this trial is testing

Treatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 19
Testing effectiveness (Phase 2)Looking for participantsNCT06797297
What this trial is testing

Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal or Acral Melanoma Who Had Not Previously Received Systemic Therapy

Who this might be right for
Melanoma
Innovent Biologics (Suzhou) Co. Ltd. 180
Testing effectiveness (Phase 2)Study completedNCT00424515
What this trial is testing

Imatinib in Patients With Mucosal or Acral/Lentiginous Melanoma

Who this might be right for
Mucosal MelanomaAcral/Lentiginous MelanomaChronically Sun Damaged Melanomas
Dana-Farber Cancer Institute 24
Testing effectiveness (Phase 2)Study completedNCT00470470
What this trial is testing

Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Acral Lentiginous Malignant MelanomaRecurrent MelanomaStage IIIA Melanoma+3 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Ended earlyNCT04244552
What this trial is testing

A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies

Who this might be right for
Breast CancerColorectal CancerOvarian Cancer+13 more
Atreca, Inc. 87
Testing effectiveness (Phase 2)Ended earlyNCT01120275
What this trial is testing

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma

Who this might be right for
Acral Lentiginous Malignant MelanomaLentigo Maligna Malignant MelanomaNodular Malignant Melanoma+4 more
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT02519322
What this trial is testing

Neoadjuvant and Adjuvant Checkpoint Blockade

Who this might be right for
Cutaneous MelanomaMucosal MelanomaOcular Melanoma+8 more
M.D. Anderson Cancer Center 53
Next Page